These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19152207)

  • 21. Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatment.
    Cohen LR; Tross S; Pavlicova M; Hu MC; Campbell AN; Nunes EV
    Am J Drug Alcohol Abuse; 2009; 35(5):305-10. PubMed ID: 19637103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient induction to methadone maintenance treatment for heroin addiction.
    Nichols AW; Salwen MB; Torrens PR
    Arch Intern Med; 1971 May; 127(5):903-9. PubMed ID: 5560867
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.
    Sindelar JL; Olmstead TA; Peirce JM
    Addiction; 2007 Sep; 102(9):1463-71. PubMed ID: 17645428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of drop-outs from a methadone program for natcotic addicts.
    Rosenberg CM; Davidson GE; Patch VD
    Int J Addict; 1972; 7(3):415-25. PubMed ID: 5085275
    [No Abstract]   [Full Text] [Related]  

  • 27. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of stimulant misusers: one year follow-up results from the national treatment outcome research study (NTORS).
    Gossop M; Marsden J; Stewart D
    Addict Behav; 2000; 25(4):509-22. PubMed ID: 10972443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming cocaine or stimulant addiction. Medications offer modest help; vaccines are in development.
    Harv Ment Health Lett; 2009 Mar; 25(9):6-7. PubMed ID: 19368038
    [No Abstract]   [Full Text] [Related]  

  • 30. Addiction Severity Index scores of four racial/ethnic and gender groups of methadone maintenance patients.
    Brown LS; Alterman AI; Rutherford MJ; Cacciola JS; Zaballero AR
    J Subst Abuse; 1993; 5(3):269-79. PubMed ID: 8312732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a methadone treatment program.
    Cushman P
    Hospitals; 1973 Jun; 47(11):67-9. PubMed ID: 4706559
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
    Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
    Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial.
    Carroll KM; Nich C; Shi JM; Eagan D; Ball SA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):224-31. PubMed ID: 22695473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.
    Kelly SM; Oʼgrady KE; Jaffe JH; Gandhi D; Schwartz RP
    J Addict Med; 2013; 7(2):133-8. PubMed ID: 23455877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychostimulant treatment of cocaine dependence.
    Mariani JJ; Levin FR
    Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges and outcomes of parallel care for patients with co-occurring psychiatric disorder in methadone maintenance treatment.
    King VL; Brooner RK; Peirce J; Kolodner K; Kidorf M
    J Dual Diagn; 2014; 10(2):60-7. PubMed ID: 24976801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.